AU615572B2 - Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles - Google Patents

Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles Download PDF

Info

Publication number
AU615572B2
AU615572B2 AU41361/89A AU4136189A AU615572B2 AU 615572 B2 AU615572 B2 AU 615572B2 AU 41361/89 A AU41361/89 A AU 41361/89A AU 4136189 A AU4136189 A AU 4136189A AU 615572 B2 AU615572 B2 AU 615572B2
Authority
AU
Australia
Prior art keywords
compound
carbon atoms
diphenyl
imidazol
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU41361/89A
Other languages
English (en)
Other versions
AU4136189A (en
Inventor
Jeffrey Thomas Billheimer
Peter John Gillies
Wendell Wilkie Wilkerson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of AU4136189A publication Critical patent/AU4136189A/en
Application granted granted Critical
Publication of AU615572B2 publication Critical patent/AU615572B2/en
Assigned to DU PONT MERCK PHARMACEUTICAL COMPANY, THE reassignment DU PONT MERCK PHARMACEUTICAL COMPANY, THE Alteration of Name(s) of Applicant(s) under S113 Assignors: E.I. DU PONT DE NEMOURS AND COMPANY
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU41361/89A 1988-09-14 1989-09-14 Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles Ceased AU615572B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/244,170 US4900744A (en) 1988-09-14 1988-09-14 Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles
US244170 1988-09-14

Publications (2)

Publication Number Publication Date
AU4136189A AU4136189A (en) 1990-03-22
AU615572B2 true AU615572B2 (en) 1991-10-03

Family

ID=22921646

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41361/89A Ceased AU615572B2 (en) 1988-09-14 1989-09-14 Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles

Country Status (13)

Country Link
US (1) US4900744A (en:Method)
EP (1) EP0359197B1 (en:Method)
JP (1) JPH02174762A (en:Method)
KR (1) KR900004697A (en:Method)
AT (1) ATE83772T1 (en:Method)
AU (1) AU615572B2 (en:Method)
DE (1) DE68904018T2 (en:Method)
DK (1) DK451389A (en:Method)
ES (1) ES2053896T3 (en:Method)
GR (1) GR3006839T3 (en:Method)
IL (1) IL91620A0 (en:Method)
NZ (1) NZ230624A (en:Method)
ZA (1) ZA897022B (en:Method)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
CA2071497A1 (en) * 1989-12-12 1991-06-13 Andrew William Bridge 2-substituted 4,5-diphenyl-imidazoles
KR927003576A (ko) * 1990-01-12 1992-12-18 로오느-푸우랜크 로레르 소시에테 아노님 2-치환 4,5-디페닐-이미다졸
US5011851A (en) * 1990-02-13 1991-04-30 Bristol-Myers Squibb Co. Imidazole carboxylic acids and esters and inhibition of blood platelet aggregation therewith
GB9019838D0 (en) * 1990-09-11 1990-10-24 Smith Kline French Lab Compounds
US5179117A (en) * 1991-12-20 1993-01-12 Du Pont Merck Pharmaceutical Company Antihypercholesterolemic 2-substituted imidazoles
US5310748A (en) * 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
US5364875A (en) * 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
AU5322494A (en) 1992-10-02 1994-04-26 Trustees Of Dartmouth College Bispecific reagents for redirected targeting of low density lipoprotein
US5491152A (en) * 1994-03-23 1996-02-13 The Du Pont Merck Pharmaceutical Company Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4367685A (en) * 1984-06-18 1986-01-02 Smithkline Beckman Corporation 2-thio-imidazolyl derivatives
AU7119187A (en) * 1986-04-08 1987-10-15 Smithkline Beckman Corporation Ester prodrugs of dopamine-beta-hydroxylase inhibitors
AU2930689A (en) * 1987-12-29 1989-08-01 Smithkline Beckman Corporation 2-carboxyalkylthioimidazoles and esters thereof as dopamine-beta-hydroxylase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US465438A (en) * 1891-12-15 Alcide frangois trouard
US3636003A (en) * 1969-11-17 1972-01-18 Geigy Chem Corp Substituted 2-mercaptoimidazole derivatives
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3228271A1 (de) * 1982-07-29 1984-02-02 A. Nattermann & Cie GmbH, 5000 Köln Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3323870A1 (de) * 1983-07-02 1985-01-03 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazol-2-ylthioalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4734421A (en) * 1986-10-29 1988-03-29 Merck & Co., Inc. Anti-inflammatory substituted 2-benzyl-mercapto-imidazole and pyrimidine derivatives compositions and method of use therefor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4367685A (en) * 1984-06-18 1986-01-02 Smithkline Beckman Corporation 2-thio-imidazolyl derivatives
AU7119187A (en) * 1986-04-08 1987-10-15 Smithkline Beckman Corporation Ester prodrugs of dopamine-beta-hydroxylase inhibitors
AU2930689A (en) * 1987-12-29 1989-08-01 Smithkline Beckman Corporation 2-carboxyalkylthioimidazoles and esters thereof as dopamine-beta-hydroxylase inhibitors

Also Published As

Publication number Publication date
GR3006839T3 (en:Method) 1993-06-30
KR900004697A (ko) 1990-04-12
ATE83772T1 (de) 1993-01-15
ZA897022B (en) 1991-05-29
DE68904018D1 (de) 1993-02-04
AU4136189A (en) 1990-03-22
EP0359197B1 (en) 1992-12-23
DK451389A (da) 1990-03-15
JPH02174762A (ja) 1990-07-06
DK451389D0 (da) 1989-09-13
EP0359197A1 (en) 1990-03-21
IL91620A0 (en) 1990-04-29
US4900744A (en) 1990-02-13
DE68904018T2 (de) 1993-04-29
ES2053896T3 (es) 1994-08-01
NZ230624A (en) 1991-06-25

Similar Documents

Publication Publication Date Title
US4900744A (en) Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles
US3991106A (en) 16-Ethers of 8-aza-9-dioxothia-11,12-seco-prostaglandins
AU637098B2 (en) Substituted pyrrole compounds and their applications in pharmacy
EP0005545A2 (de) Neue Imidazolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
FR2572725A1 (fr) Ethers bicycloheptane-substitues a action therapeutique
US4055596A (en) 11,12-Seco-prostaglandins
US4260771A (en) Interphenylene 9-thia-11-oxo-12-azaprostanoic acid compounds
US3991087A (en) 8-Halo-11,12-secoprostaglandins
DE2156472A1 (de) Verfahren zur Herstellung von neuen Diazepinderivaten
US4066675A (en) 9-thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins and processes
IE50574B1 (en) 4,5-unsaturated prostanoic acid derivatives
SU1272990A3 (ru) Способ получени производных диазабицикло /3,3,1/ нонана или их солей
US4526900A (en) 7-Oxabicycloheptane substituted oxa prostaglandin analogs and their use in the treatment of thrombolytic disease
US5679703A (en) Tricyclic compounds having ACAT inhibiting activity
US4611006A (en) 5,6-epoxy-7-oxabicycloheptane substituted ethers useful in the treatment of thrombotic disease
US4542151A (en) Tetrahydrothienyl substituted ethers
EP0016587B1 (en) 1-((substituted-naphthyl)ethyl)-imidazole derivatives, pharmaceutical compositions containing them and methods of making them
US4312882A (en) Thienyoxy and furyl containing analogs of prostacyclin and their use as medicaments
US3852303A (en) PROCESS FOR IMIDAZO{8 2,1-a{9 ISOINDOLES AND INTERMEDIATES
US3754006A (en) Esters and amides of substituted glyoxylic acids
FR2563522A1 (fr) Analogues de 7 oxabicycloheptane prostaglandines, a action anti-inflammatoire, analgesique et cardiovasculaire
US4816458A (en) Method of treating hyperploliferative skin disease with substituted-2,3-dihydro-6-substituted -pyrimido[2,1]-purine-4,8(1H,9H)diones
US4304783A (en) Thienyl, thienyloxy or furyl substituted prostaglandin derivatives in the 6-keto-PGE1 series
US4952602A (en) Phenyl benzothiophene hypolipidemic derivatives
US4322543A (en) 4,5-Unsaturated prostanoic acid derivatives